Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

4 results
Display

Radiotherapy of the Malignant Gliomas

Choi MS

  • KMID: 2068179
  • J Korean Neurosurg Soc.
  • 1984 Jun;13(2):245-248.
The outlook for patients with malignant gliomas of the brain remains rather poor. However, after many experience of decades, the data indicate that some improvements seemed to have occurred with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Biodistribution of Iodine-131-Iodomisonidazole and Imaging of Tumor Hypoxia in Mice bearing CT-26 Adenocarcinoma

Kim HW, Kim CG, Yoon KH, Kim HJ, Juhng SK, Roh BS, Yang DJ, Kim EE, Lee HC

  • KMID: 1926584
  • Korean J Nucl Med.
  • 1999 Jun;33(3):289-297.
urpose: Misonidazole is a radiosensitizer that binds in hypoxic cells. The purpose of this study was to find out the feasibility of I-131-Iodomisonidazole (IMISO) for imaging of tumor hypoxia. MATERIALS...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of Combination of Anticancer Agents and Nitroimidazoles on the Survival of Human Hepatocellular Carcinoma Cells under Hypoxic Conditions

Lim SH, Lee JY, Park SH, Kim YH, Suh HS, Park JB, Lee J

PURPOSE: In a previous study, we have shown that anticancer agents inhibiting topoisomerases improve survival of tumor cells under hypoxic condition. In the present study, we evaluated whether and how...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Nucleophilic Fluorination Reactions in Novel Reaction Media for 18F-Fluorine Labeling Method

Kim DW, Jeong HJ, Lim ST, Sohn MH

  • KMID: 2313076
  • Nucl Med Mol Imaging.
  • 2009 Apr;43(2):91-99.
Noninvasive imaging of molecular and biological processes in living subjects with positron emission tomography (PET) provides exciting opportunities to monitor metabolism and detect diseases in humans. Measuring these processes with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr